These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3500976)
1. Lymphoma models for B cell activation and tolerance. VI. Reversal of anti-Ig-mediated negative signaling by T cell-derived lymphokines. Scott DW; O'Garra A; Warren D; Klaus GG J Immunol; 1987 Dec; 139(12):3924-9. PubMed ID: 3500976 [TBL] [Abstract][Full Text] [Related]
2. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium. Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921 [TBL] [Abstract][Full Text] [Related]
3. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
4. Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Pennell CA; Scott DW Eur J Immunol; 1986 Dec; 16(12):1577-81. PubMed ID: 3493148 [TBL] [Abstract][Full Text] [Related]
5. Role of DNA synthesis in secretion of immunoglobulin from murine B cells stimulated by T cell derived lymphokines. Simpson LG; Isakson PC J Immunol; 1986 Sep; 137(6):1797-802. PubMed ID: 3091690 [TBL] [Abstract][Full Text] [Related]
6. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells. Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637 [TBL] [Abstract][Full Text] [Related]
7. Regulation of an idiotype+ B cell lymphoma. Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion. Ward RE; McNamara-Ward M; Webb CF; Altman D; Lim PL; Tucker PW; Kohler H J Immunol; 1988 Jul; 141(1):340-6. PubMed ID: 3259969 [TBL] [Abstract][Full Text] [Related]
8. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction. Phillips NE; Gravel KA; Tumas K; Parker DC J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056 [TBL] [Abstract][Full Text] [Related]
9. A polyclonal model for B cell tolerance. I. Fc-dependent and Fc-independent induction of nonresponsiveness by pretreatment of normal splenic B cells with anti-Ig. Warner GL; Scott DW J Immunol; 1991 Apr; 146(7):2185-91. PubMed ID: 1672346 [TBL] [Abstract][Full Text] [Related]
10. Lymphoma models for B cell activation and tolerance. I. Conditions for the anti-mu-dependent stimulation of growth in NBL, a nude B cell lymphoma. Ling M; Livnat D; Pillai PS; Scott DW J Immunol; 1985 Mar; 134(3):1449-54. PubMed ID: 2578509 [TBL] [Abstract][Full Text] [Related]
11. Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. Justement LB; Kreiger J; Cambier JC J Immunol; 1989 Aug; 143(3):881-9. PubMed ID: 2663989 [TBL] [Abstract][Full Text] [Related]
12. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation. Baluyut AR; Subbarao B J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924 [TBL] [Abstract][Full Text] [Related]
13. Constitutive production of lymphokines by cloned murine B-cell lymphomas--CH12 B lymphoma produces interleukin-4. O'Garra A; Barbis D; Harada N; Lee F; Howard M J Mol Cell Immunol; 1989; 4(3):149-58; discussion 158-9. PubMed ID: 2788429 [TBL] [Abstract][Full Text] [Related]
14. B cells from M167 mu kappa transgenic mice fail to proliferate after stimulation with soluble anti-Ig antibodies. A model for antigen-induced B cell anergy. Sieckmann DG; Holmes K; Hornbeck P; Martin E; Guelde G; Bondada S; Longo DL; Kenny JJ J Immunol; 1994 May; 152(10):4873-83. PubMed ID: 8176209 [TBL] [Abstract][Full Text] [Related]
15. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. Muraguchi A; Kehrl JH; Butler JL; Fauci AS J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443 [TBL] [Abstract][Full Text] [Related]
16. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1. Tamura GS; McGrath MS; Weissman IL J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925 [TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine on responses of murine B cells to T cell-derived lymphokines. O'Garra A; Warren DJ; Holman M; Popham AM; Sanderson CJ; Klaus GG J Immunol; 1986 Oct; 137(7):2220-4. PubMed ID: 3489759 [TBL] [Abstract][Full Text] [Related]
18. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products. Jakway JP; Usinger WR; Gold MR; Mishell RI; DeFranco AL J Immunol; 1986 Oct; 137(7):2225-31. PubMed ID: 3489760 [TBL] [Abstract][Full Text] [Related]
19. Anergy in immature B lymphocytes. Differential responses to receptor-mediated stimulation and T helper cells. Chang TL; Capraro G; Kleinman RE; Abbas AK J Immunol; 1991 Aug; 147(3):750-6. PubMed ID: 1830597 [TBL] [Abstract][Full Text] [Related]
20. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]